SecBot SecBot

EHC

Encompass Health Corp
NYSE· Services-Hospitals· Inc. DE· CIK 0000785161 Healthcare & Medical Devices
$142.11 +1.12 (+0.79%)
Nov 16 4:00 PM ET · prev $140.99
Market cap
$13.8B
Large cap
Consensus
Buy
94% Buy or better · 18 analysts
Median target
$155.00
+9% · range $142.00–177.00
1 year
+26.9%
from $112.00 · Nov 17
30 days
+16.8%
from $121.71
52-week range
$93.83–142.51
−0% from high · low Feb 2
Avg volume 20D
1.14M
shares / day
Short interest
3.61M
≈3.7% of shares · +9.1%
Days to cover
2.7
at average volume
Insider net
−$29.5M
0 buyers · 5 sellers · since Apr 15
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
13
analyzed by SecBot
SecBot read BULLISH 8 reports · 90 days
Balance 0 bearish · 2 bullish · 1 mixed · 5 neutral oldest → newest, height = score
Avg score ·High conf. 6/8

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    5 insiders sold $29.5M.

  • InstitutionsMIXED

    Q2 2026: 30 added (0 new), 25 trimmed or exited.

  • AnalystsBULLISH

    17 of 18 rate it Buy or better. Median target $155.00 (+9%).

  • Short sellersSTEADY

    Short interest +9.1% to 3.61M shares. 2.7 days to cover, ≈3.7% of shares.

  • TrendUPTREND

    12% above its 50-day average. New closing high $142.51 on Nov 10.

  • SocialQUIET

    No Reddit mentions this week. Last mention Nov 9.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
CITADEL ADVISORS LLCDOUBLED2,563,104$259.1M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLCADD1,151,085$116.4M
MORGAN STANLEYADD1,146,873$115.9M
AMERICAN CENTURY COMPANIES INCADD1,050,470$106.2M
BROWN ADVISORY INCADD1,012,731$102.4M
Holocene Advisors, LPDOUBLED977,634$98.8M
MILLENNIUM MANAGEMENT LLCADD805,717$81.4M
JANE STREET GROUP, LLCDOUBLED582,596$58.9M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

18 analysts
Buy 94% rate it Buy or better
Strong Buy7Buy10Hold1Sell0Strong Sell0
12-month targets · 12 analysts

Price is inside the target range. Median implies +9%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Oct 30, 2026UBS
MAINTAIN
MAINTAINBuy
Oct 30, 2026TD Cowen
MAINTAIN
MAINTAINBuy
Oct 30, 2026Truist Securities
REITERATE
REITERATEBuy
Oct 30, 2026Keybanc
MAINTAIN
MAINTAINOverweight
Oct 29, 2026Barclays
MAINTAIN
MAINTAINOverweight
Aug 10, 2026TD Cowen
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$29.5M
sold · 5 insiders
DateInsiderTypeValue
Oct 19, 2026
Reidy Christopher R
Director
Oct 19, 2026
AWARD$36.0K
Oct 19, 2026
Christie Edward M III
Director
Oct 19, 2026
AWARD$28.0K
Oct 15, 2026
KATZ LESLYE G
Director
Oct 15, 2026
AWARD81 sh
Oct 15, 2026
O'Connor Kevin J.
Director
Oct 15, 2026
AWARD18 sh
Oct 15, 2026
Hayes Cain A
Director
Oct 15, 2026
AWARD4 sh
Oct 15, 2026
Reidy Christopher R
Director
Oct 15, 2026
AWARD20 sh
Oct 15, 2026
Christie Edward M III
Director
Oct 15, 2026
AWARD11 sh
Oct 15, 2026
HERMAN JOAN E
Director
Oct 15, 2026
AWARD81 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Washington

Corporate Lobbying

43 lobbying filings and 2 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
3,613,983
shares short
+9.1%
vs prior settlement
2.7
days to cover
≈3.7%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 6, 2026 SEC
Encompass Health disclosed the indefinite closure of its 90-bed Sea Pines Rehabilitation Hospital in Florida due to…
8-K · Impact 4/10
Oct 28, 2026 SEC
Encompass Health reported Q3 2026 net operating revenue of $1,609.5M (up 8.9% YoY) and adjusted EPS of $1.52 (up 23.6%…
8-K · Impact 6/10
Oct 28, 2026 SEC
Encompass Health reported Q3 2026 adjusted EPS of $1.52, beating the $1.36 consensus by 11.8%, on revenue of $1.6095B…
PRESS-RELEASE · Impact 6/10
Oct 28, 2026 Earnings
Encompass Health reports results for third quarter 2026
Increases full-year guidance BIRMINGHAM, Ala., Oct. 28, 2026 /PRNewswire/ -- Encompass Health Corpor
Oct 22, 2026 Press
Encompass Health declared a quarterly cash dividend of $0.21 per share, payable Jan. 15, 2027, to holders of record…
Impact 2/10
Oct 19, 2026 Insider
Reidy Christopher R was granted 284 shares
Director @ $126.89 ($36.0K)
Oct 19, 2026 Insider
Christie Edward M III was granted 221 shares
Director @ $126.63 ($28.0K)
Oct 15, 2026 Insider
KATZ LESLYE G was granted 81 shares
Director
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

13 filings · 1 press release · 4 bullish · 1 bearish · 1 mixed · 7 neutral
All EHC filing & press-release reports (14)